J.-P. Utille, I. Jeacomine / Carbohydrate Research 342 (2007) 2649–2656
2653
0
0
0
0
ence of 5 and small amounts of 6, 7. Total yield for the
coupling: 82%, 13: 0.10 mmol, 11: 0.50 mmol, 5:
0.14 mmol, 6, 7: 0.08 mmol.
5.64 (dd, 1H, H-30, J2 ,3 2.47 Hz, J3 ,4 5.78 Hz), 5.53
(br d, 1H, H-20, J1 ,2 <0.5 Hz), 5.43 (d, 1H, H-10),
5.26, 5.06 (m, 2H, CH2@CH–), 5.01 (d, 1H, H-1, J1,2
0
0
3.61 Hz), 4.76 (dd, 1H, H-50a, J4 ,5 a 3.40 Hz, J5 a,5 b
0
0
0
0
1.5. Allyl 2,3,5-tri-O-benzoyl-a-L-arabinofuranosyl-
(1!3)-a-D-xylopyranoside (5)
10.90 Hz), 4.64 (m, 1H, H-40), 4.61 (dd, 1H, H-50b,
0
0
J4 ,5 b 5.35 Hz), 4.18 (m, 1H, CH2@CH–CH2O–), 3.98
(t, 1H, H-3, J2,3 = J3,4 9.10 Hz), 3.94 (m, 1H,
CH2@CH–CH2O–), 3.72 (m, 1H, H-4), 3.68 (dd, 1H,
H-5a, J4,5a 5.46 Hz, J5a,5b 10.44 Hz), 3.57 (t, 1H, H-5b,
J4,5b 10.44 Hz), 3.52 (dd, 1H, H-2). 13C NMR
(100 MHz, CDCl3): d 166.2–165.6 (3C, PhCO), 133.8–
128.4 (18C, arom C; 1C, CH2@CH–), 117.5 (1C,
CH2@CH–), 107.9 (C-10), 97.5 (C-1), 83.3 (C-20), 80.3
(C-2), 80.1 (C-40), 77.1 (C-30), 73.2 (C-3), 70.1 (C-4),
68.4 (1C, CH2@CH–CH2O–), 63.6 (C-50), 61.1 (C-5);
ESIMS: m/z 657.3 [M+Na]+.
Product 5 was isolated as a syrup (158 mg, 0.25 mmol);
[a]D +51.6 (c 1.0, CHCl3), Rf 0.53 (3:2, toluene/EtOAc);
1H NMR (400 MHz, CDCl3): d 8.15–7.15 (m, 15H,
arom H), 5.92 (m, 1H, CH2@CH–), 5.67 (dd, 1H, H-
30, J2 ,3 2.93 Hz, J3 ,4 5.86 Hz), 5.58 (dd, 1H, H-20,
0
0
0
0
J1 ,2 0.98 Hz), 5.52 (br s, H10, 1H), 5.30, 5.20 (m, 2H,
CH2@CH–), 4.91 (d, 1H, H-1, J1,2 2.98 Hz), 4.79–4.73
0
0
(m, 2H, H-40, H-50a, J4 ,5 a 3.42 Hz, J4 ,5 b 6.83 Hz,
0
0
0
0
J5 a,5 b 12.0 Hz), 4.62 (dd, 1H, H-50b), 4.22, 4.03 (m,
2H, CH2@CH–CH2O–), 3.77 (dd, 1H, H-5a, J4,5a
5.59 Hz), 3.76 (t, 1H, H-3, J2,3 = J3,4 7.91 Hz), 3.74
(dd, 1H, H-2), 3.70 (m, 1H, H-4), 3.58 (t, 1H, H-5b,
J4,5b = J5a,5b 11.90 Hz); 13C NMR (100 MHz, CDCl3):
d 165.7–165.5 (3C, 3PhCO), 133.8–128.2 (18C, arom
C; 1C, CH2@CH–), 118.1 (1C, CH2@CH–), 107.7 (C-
10), 97.1 (C-1), 84.5 (C-3), 82.8 (C-20), 80.4 (C-40), 77.0
(C-30), 71.2 (C-2), 68.7 (CH2@CH–CH2–O–), 68.4 (C-
4), 63.8 (C-50), 61.8 (C-5); ESIMS: m/z 657.3 [M+Na]+.
0
0
1.8. Allyl 2,3-di-O-(2,3,5-tri-O-benzoyl-a-L-arabinofur-
anosyl)-a-D-xylopyranoside (11)
Amorphous solid; [a]D +33.8 (c 1.0, CHCl3); TLC Rf
0.72 (3:2, toluene/EtOAc), Rf 0.14 in (9:1, toluene/
EtOAc); H NMR (400 MHz, CDCl3): d 7.15–8.15 (m,
1
30H, arom H), 5.77 (m, 1H, CH2@CH–), 5.65 (1s, 2
br d, 3H, H-10, H-20, H-200), 5.61 (1s, 1H, H-100,
J1 ,2 <0.5 Hz), 5.59 (br d, 1H, H-300, J3 4 3.81 Hz),
00 00
00 00
1.6. Allyl 2,3,5-tri-O-benzoyl-a-L-arabinofuranosyl-
(1!4)-a-D-xylopyranoside (6)
5.54 (br d, 1H, H-30, J3 ,4 4.84 Hz), 5.24 (m, 1H,
CH2@CH–), 5.04 (m, 1H, CH2@CH–), 4.99 (d, 1H, H-
0
0
1), 4.80 (dd 1H, H-50a, J4 ,5 a 3.23 Hz), 4.78 (dd, 1H,
0
0
Pure compound 6 was isolated during the preparation of
7c from a mixture of 6 and 7 (see 7c). Amorphous solid;
[a]D +38.5 (c 1.0, CHCl3), Rf 0.19 (3:2, toluene/EtOAc);
1H NMR (400 MHz, CDCl3): d 8.15–7.15 (m, 15H,
arom H), 5.91 (m, 1H, CH2@CH–), 5.57 (dd, 1H, H-
H-500a, J4 ,5 a 4.80 Hz), 4.76 (m, 1H, H-400), 4.66 (dd,
00 00
1H, H-50b, J4 ,5 b 5.98 Hz), 4.62 (m, 1H, H-500b, J4 ,5 b
6.40 Hz), 4.56 (m, 1H, H-40), 4.15 (m, 1H, CH2@CH–
CH2O-), 4.03 (dd, 1H, H-3, J2,3 9.58 Hz, J3,4 8.11 Hz),
3.91 (m, 1H, CH2@CH–CH2O-), 3.80 (dd, 1H, H-2),
3.74 (m, 1H, H-4), 3.72 (dd, 1H, H-5a, J4,5a 3.25 Hz,
J5a,5b 12.10 Hz), 3.58 (t, 1H, H-5b, J4,5b 12.10 Hz); 13C
NMR (100 MHz, CDCl3): d 165.9–165.1 (6C, 6PhCO),
133.4–128.1 (36C, arom C; 1C, CH2@CH–), 117.3 (1C,
CH2@CH–), 107.7 (C-10), 107.6 (C-100), 97.6 (C-1),
82.3, 82.2 (C-200, C-3), 81.8–81.6 (C-20, C-40, C-400),
77.8 (C-30), 77.5 (C-300), 77.3 (C-2), 69.5 (C-4), 68.3
(CH2@CH–CH2O–), 63.9 (C-50, C-500), 61.3 (C-5);
ESIMS: m/z 1101.6 [M+Na]+.
0
0
00 00
30, J2 ,3 1.44 Hz, J3 ,4 4.51 Hz), 5.48 (br d, 1H, H-20,
0
0
0
0
J1 ,2 <0.5 Hz), 5.39 (br s, 1H, H-10), 5.33, 5.29 (m, 2H,
CH2@CH–), 4.85 (d, 1H, H-1, J1,2 3.79 Hz), 4.80 (dd,
0
0
1H, H-50a, J4 ,5 a 3.71 Hz, J5 a,5 b 10.93 Hz), 4.77 (m,
0
0
0
0
1H, H-40), 4.65 (dd, 1H, H-50b, J4 ,5 b 4.26 Hz), 4.22,
4.02 (m, 2H, CH2@CH–CH2O–), 3.84 (t, 1H, H-3,
J2,3 = J3,4 9.20 Hz), 3.77 (dd, 1H, H-5a, J4,5a, 5.23 Hz,
J5a,5b 10.95 Hz), 3.74 (m, 1H, H-4), 3.63 (t, 1H, H-5b,
J4,5b 10.95 Hz), 3.57 (dd, 1H, H-2); 13C NMR
(100 MHz, CDCl3): d 166.2, 165.7, 165.5 (3C, 3PhCO),
133.7–128.2 (18C, arom C; 1C, CH2@CH–), 117.9
(CH2@CH–), 105.3 (C-10), 97.1 (C-1), 82.0 (C-20), 81.4
(C-40), 77.4 (C-30), 76.8 (C-4) 73.3 (C-3), 72.2 (C-2),
68.6 (1C, CH2@CH–CH2O–), 63.6 (C-50), 59.4 (C-5);
ESIMS: m/z 657.3 [M+Na]+.
0
0
1.9. Allyl 2,3,4-tri-O-(2,3,5-tri-O-benzoyl-a-L-arabino-
furanosyl)-a-D-xylopyranoside (13)
Amorphous solid; [a]D +26.63 (c 1.0, CHCl3); TLC Rf
0.36 (9:1, toluene/EtOAc); 13C NMR (100 MHz,
CDCl3): d 166.1–165.1 (9C, 9PhCO), 133.5–128.1 (54C,
arom C; 1C, CH2@CH–), 117.1 (1C, CH2@CH–),
107.6, 106.1, 105.8 (C-10, C-100, C-1000, Ara), 97.7 (C-1,
Xyl), 82.3, 82.2, 081.9, 81.7, 81.5, 81.4, 80.8, 78.2, 77.4,
77.0 (10 C, C-2 , C-200, C-2000, C-3, C-30, C-300, C-3000,
C-40, C-400, C-4000), 74.2, 73.8 (C-2, C-4), 68.4 (1C,
1.7. Allyl 2,3,5-tri-O-benzoyl-a-L-arabinofuranosyl-
(1!2)-a-D-xylopyranoside (7)
Amorphous solid; [a]D +50.2 (c 1.0, CHCl3); Rf 0.19
1
(3:2, toluene/EtOAc); H NMR (400 MHz, CDCl3): d
8.15–7.15 (m, 15H, arom H), 5.83 (m, 1H, CH2@CH–),